Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases

BACKGROUNDMicrosatellite instability (MSI) is a predictive biomarker for cancer immunotherapy. The tumor-agnostic nature of MSI makes it a denominator for immunotherapy in several solid tumors. It can be assessed using next-generation sequencing (NGS), fluorescent multiplex PCR, and immunohistochemi...

Full description

Saved in:
Bibliographic Details
Published in:World journal of clinical cases 2023, Vol.11 (13), p.3105-3113
Main Authors: Şenocak Taşçı, Elif, Yıldız, İbrahim, Erdamar, Sibel, Özer, Leyla
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 3113
container_issue 13
container_start_page 3105
container_title World journal of clinical cases
container_volume 11
creator Şenocak Taşçı, Elif
Yıldız, İbrahim
Erdamar, Sibel
Özer, Leyla
description BACKGROUNDMicrosatellite instability (MSI) is a predictive biomarker for cancer immunotherapy. The tumor-agnostic nature of MSI makes it a denominator for immunotherapy in several solid tumors. It can be assessed using next-generation sequencing (NGS), fluorescent multiplex PCR, and immunohistochemistry (IHC). CASE SUMMARYHere, we report 3 cases with discordant MSI results detected using different methods. A cholangiocellular carcinoma case revealed proficient mismatch repair (MMR) by IHC but high MSI (MSI-H) by liquid NGS. A cervical cancer case revealed deficient MMR by IHC, microsatellite stable by PCR, and MSI-H by NGS. Lastly, an endometrial cancer case revealed proficient MMR by IHC but MSI-H by NGS. CONCLUSIONIHC for MMR status is the first choice due to several advantages. However, in cases of indeterminate IHC results, molecular testing by MSI-PCR is preferred. Recently, NGS-based MSI assays are being widely used to detect MSI-H tumors. All three methods have high accuracy; however, the inconsistencies between them may lead to misdiagnosis.
doi_str_mv 10.12998/wjcc.v11.i13.3105
format report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2818055484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2818055484</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_28180554843</originalsourceid><addsrcrecordid>eNqVjj1PAzEMhiMEEhX0D3TyyHJHfOmVHCsfYq7Yq5C6bapcfMQpqP-eDAysTH786pH9KrVA3WI3DPb---h9-4XYBjStQd1fqFln9ENjh5W-_MPXai5y1FpjlXBlZmp6DuIzTS75M7iR0x7G4DOLKxRjKAQhSXEfofIZtlTIl8AJRioH3nLkfSCpDiROja97roKL4OtByo-wpolzAd6BqZmQ3KqrnYtC8995o-5eX96f3pop8-eJpGzG2qj-don4JJvOotV9v7RL8w_1B4eMWDk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2818055484</pqid></control><display><type>report</type><title>Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases</title><source>PubMed Central</source><creator>Şenocak Taşçı, Elif ; Yıldız, İbrahim ; Erdamar, Sibel ; Özer, Leyla</creator><creatorcontrib>Şenocak Taşçı, Elif ; Yıldız, İbrahim ; Erdamar, Sibel ; Özer, Leyla</creatorcontrib><description>BACKGROUNDMicrosatellite instability (MSI) is a predictive biomarker for cancer immunotherapy. The tumor-agnostic nature of MSI makes it a denominator for immunotherapy in several solid tumors. It can be assessed using next-generation sequencing (NGS), fluorescent multiplex PCR, and immunohistochemistry (IHC). CASE SUMMARYHere, we report 3 cases with discordant MSI results detected using different methods. A cholangiocellular carcinoma case revealed proficient mismatch repair (MMR) by IHC but high MSI (MSI-H) by liquid NGS. A cervical cancer case revealed deficient MMR by IHC, microsatellite stable by PCR, and MSI-H by NGS. Lastly, an endometrial cancer case revealed proficient MMR by IHC but MSI-H by NGS. CONCLUSIONIHC for MMR status is the first choice due to several advantages. However, in cases of indeterminate IHC results, molecular testing by MSI-PCR is preferred. Recently, NGS-based MSI assays are being widely used to detect MSI-H tumors. All three methods have high accuracy; however, the inconsistencies between them may lead to misdiagnosis.</description><identifier>ISSN: 2307-8960</identifier><identifier>EISSN: 2307-8960</identifier><identifier>DOI: 10.12998/wjcc.v11.i13.3105</identifier><language>eng</language><ispartof>World journal of clinical cases, 2023, Vol.11 (13), p.3105-3113</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Şenocak Taşçı, Elif</creatorcontrib><creatorcontrib>Yıldız, İbrahim</creatorcontrib><creatorcontrib>Erdamar, Sibel</creatorcontrib><creatorcontrib>Özer, Leyla</creatorcontrib><title>Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases</title><title>World journal of clinical cases</title><description>BACKGROUNDMicrosatellite instability (MSI) is a predictive biomarker for cancer immunotherapy. The tumor-agnostic nature of MSI makes it a denominator for immunotherapy in several solid tumors. It can be assessed using next-generation sequencing (NGS), fluorescent multiplex PCR, and immunohistochemistry (IHC). CASE SUMMARYHere, we report 3 cases with discordant MSI results detected using different methods. A cholangiocellular carcinoma case revealed proficient mismatch repair (MMR) by IHC but high MSI (MSI-H) by liquid NGS. A cervical cancer case revealed deficient MMR by IHC, microsatellite stable by PCR, and MSI-H by NGS. Lastly, an endometrial cancer case revealed proficient MMR by IHC but MSI-H by NGS. CONCLUSIONIHC for MMR status is the first choice due to several advantages. However, in cases of indeterminate IHC results, molecular testing by MSI-PCR is preferred. Recently, NGS-based MSI assays are being widely used to detect MSI-H tumors. All three methods have high accuracy; however, the inconsistencies between them may lead to misdiagnosis.</description><issn>2307-8960</issn><issn>2307-8960</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2023</creationdate><recordtype>report</recordtype><recordid>eNqVjj1PAzEMhiMEEhX0D3TyyHJHfOmVHCsfYq7Yq5C6bapcfMQpqP-eDAysTH786pH9KrVA3WI3DPb---h9-4XYBjStQd1fqFln9ENjh5W-_MPXai5y1FpjlXBlZmp6DuIzTS75M7iR0x7G4DOLKxRjKAQhSXEfofIZtlTIl8AJRioH3nLkfSCpDiROja97roKL4OtByo-wpolzAd6BqZmQ3KqrnYtC8995o-5eX96f3pop8-eJpGzG2qj-don4JJvOotV9v7RL8w_1B4eMWDk</recordid><startdate>20230506</startdate><enddate>20230506</enddate><creator>Şenocak Taşçı, Elif</creator><creator>Yıldız, İbrahim</creator><creator>Erdamar, Sibel</creator><creator>Özer, Leyla</creator><scope>7X8</scope></search><sort><creationdate>20230506</creationdate><title>Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases</title><author>Şenocak Taşçı, Elif ; Yıldız, İbrahim ; Erdamar, Sibel ; Özer, Leyla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_28180554843</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Şenocak Taşçı, Elif</creatorcontrib><creatorcontrib>Yıldız, İbrahim</creatorcontrib><creatorcontrib>Erdamar, Sibel</creatorcontrib><creatorcontrib>Özer, Leyla</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Şenocak Taşçı, Elif</au><au>Yıldız, İbrahim</au><au>Erdamar, Sibel</au><au>Özer, Leyla</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases</atitle><jtitle>World journal of clinical cases</jtitle><date>2023-05-06</date><risdate>2023</risdate><volume>11</volume><issue>13</issue><spage>3105</spage><epage>3113</epage><pages>3105-3113</pages><issn>2307-8960</issn><eissn>2307-8960</eissn><abstract>BACKGROUNDMicrosatellite instability (MSI) is a predictive biomarker for cancer immunotherapy. The tumor-agnostic nature of MSI makes it a denominator for immunotherapy in several solid tumors. It can be assessed using next-generation sequencing (NGS), fluorescent multiplex PCR, and immunohistochemistry (IHC). CASE SUMMARYHere, we report 3 cases with discordant MSI results detected using different methods. A cholangiocellular carcinoma case revealed proficient mismatch repair (MMR) by IHC but high MSI (MSI-H) by liquid NGS. A cervical cancer case revealed deficient MMR by IHC, microsatellite stable by PCR, and MSI-H by NGS. Lastly, an endometrial cancer case revealed proficient MMR by IHC but MSI-H by NGS. CONCLUSIONIHC for MMR status is the first choice due to several advantages. However, in cases of indeterminate IHC results, molecular testing by MSI-PCR is preferred. Recently, NGS-based MSI assays are being widely used to detect MSI-H tumors. All three methods have high accuracy; however, the inconsistencies between them may lead to misdiagnosis.</abstract><doi>10.12998/wjcc.v11.i13.3105</doi></addata></record>
fulltext fulltext
identifier ISSN: 2307-8960
ispartof World journal of clinical cases, 2023, Vol.11 (13), p.3105-3113
issn 2307-8960
2307-8960
language eng
recordid cdi_proquest_miscellaneous_2818055484
source PubMed Central
title Discrepancy among microsatellite instability detection methodologies in non-colorectal cancer: Report of 3 cases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T22%3A18%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Discrepancy%20among%20microsatellite%20instability%20detection%20methodologies%20in%20non-colorectal%20cancer:%20Report%20of%203%20cases&rft.jtitle=World%20journal%20of%20clinical%20cases&rft.au=%C5%9Eenocak%20Ta%C5%9F%C3%A7%C4%B1,%20Elif&rft.date=2023-05-06&rft.volume=11&rft.issue=13&rft.spage=3105&rft.epage=3113&rft.pages=3105-3113&rft.issn=2307-8960&rft.eissn=2307-8960&rft_id=info:doi/10.12998/wjcc.v11.i13.3105&rft_dat=%3Cproquest%3E2818055484%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_28180554843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2818055484&rft_id=info:pmid/&rfr_iscdi=true